Ralph DeBerardinis, MD, PhD

Assistant Professor
Endowed Title: Sowell Family Scholar in Medical Research 2007-2011
Pediatrics, Eugene McDermott Center for Human Growth & Development
Graduate Program: Cancer Biology

Contact Information

UT Southwestern Medical Center
5323 Harry Hines Boulevard
Dallas, Texas 75390

ralph.deberardinis@utsouthwestern.edu

To make an appointment, call 214-730-KIDS (5437).

Biography

Ralph DeBerardinis was born, raised and educated in the Philadelphia area, earning a B.S. in Biology from St. Joseph’s University (summa cum laude) in 1992, and MD and PhD degrees from the University of Pennsylvania. For his thesis work with Dr. Haig H. Kazazian at Penn, Dr. DeBerardinis studied L1 retrotransposons in the mouse and human genomes and determined several aspects of their impact on genome fluidity and evolution. After finishing his MD-PhD training, Dr. DeBerardinis stayed in Philadelphia to become the first trainee in the combined residency program in Pediatrics and Medical Genetics at The Children’s Hospital of Philadelphia (CHOP), receiving several awards for teaching and clinical care and ultimately achieving board certification in Pediatrics, Medical Genetics and Clinical Biochemical Genetics. Dr. DeBerardinis served as an attending physician for two years in the Section of Biochemical Genetics at CHOP. Dr. DeBerardinis performed post-doctoral research training in the laboratory of Craig B. Thompson, MD in the Penn Cancer Center from 2004-2007, where he explored the connections between cellular signal transduction and core metabolic pathways in proliferating cells. These studies led to several novel observations connecting growth factor signaling with specific metabolic activities, including glycolysis, glutaminolysis, the Krebs cycle and the synthesis and degradation of fatty acids. These observations raised the possibility that different oncogenic signaling pathways regulate distinct aspects of cellular metabolism, arguing for metabolic synergy among the mutations that cause cancer. In 2008, Dr. DeBerardinis moved to Dallas to join the faculty of the University of Texas - Southwestern Medical Center as an Assistant Professor of Pediatrics and Genetics. His lab continues to focus on integrating cellular signal transduction and metabolism during both normal cell proliferation and tumorigenesis. He is also an attending physician in the Division of Pediatric Genetics and Metabolism at Children’s Medical Center, where he is involved in the diagnosis and care of children with inborn errors of metabolism.

DeBerardinis Laboratory website: http://www4.utsouthwestern.edu/McDermottLab/deB/deB_index.htm

Education

ResidencyChildren's Hospital of Philadelphia (2005)
Medical SchoolUniversity of Pennsylvania School of Medicine (2000)

Publications

Featured
Reductive carboxylation supports growth in tumour cells with defective mitochondria.

Mullen AR, Wheaton WW, Jin ES, Chen PH, Sullivan LB, Cheng T, Yang Y, Linehan WM, Chandel NS, Deberardinis RJ, Nature, 2011 Nov;

Featured
Pyruvate carboxylase is required for glutamine-independent growth of tumor cells.

Cheng T, Sudderth J, Yang C, Mullen AR, Jin ES, Matés JM, DeBerardinis RJ, Proceedings of the National Academy of Sciences of the United States of America, 2011 May; 108 (21):8674-9

Featured
Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling.

Yang C, Sudderth J, Dang T, Bachoo RM, Bachoo RG, McDonald JG, DeBerardinis RJ, Cancer research, 2009 Oct; 69 (20):7986-93

Featured
The biology of cancer: metabolic reprogramming fuels cell growth and proliferation.

DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB, Cell metabolism, 2008 Jan; 7 (1):11-20

Featured
Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis.

DeBerardinis RJ, Mancuso A, Daikhin E, Nissim I, Yudkoff M, Wehrli S, Thompson CB, Proceedings of the National Academy of Sciences of the United States of America, 2007 Dec; 104 (49):19345-50

Serine metabolism: some tumors take the road less traveled.

DeBerardinis RJ, Cell metabolism, 2011 Sep; 14 (3):285-6

Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase.

Frezza C, Zheng L, Folger O, Rajagopalan KN, MacKenzie ED, Jerby L, Micaroni M, Chaneton B, Adam J, Hedley A, Kalna G, Tomlinson IP, Pollard PJ, Watson DG, Deberardinis RJ, Shlomi T, Ruppin E, Gottlieb E, Nature, 2011 Sep; 477 (7363):225-8

Uncoupling hypoxia signaling from oxygen sensing in the liver results in hypoketotic hypoglycemic death.

Kucejova B, Sunny NE, Nguyen AD, Hallac R, Fu X, Peña-Llopis S, Mason RP, Deberardinis RJ, Xie XJ, Debose-Boyd R, Kodibagkar VD, Burgess SC, Brugarolas J, Oncogene, 2011 May; 30 (18):2147-60

Measurement of glycine in the human brain in vivo by (1) H-MRS at 3 T: application in brain tumors.

Choi C, Ganji SK, Deberardinis RJ, Dimitrov IE, Pascual JM, Bachoo R, Mickey BE, Malloy CR, Maher EA, Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine, 2011 Mar; :609-18

Glutamine: pleiotropic roles in tumor growth and stress resistance.

Shanware NP, Mullen AR, DeBerardinis RJ, Abraham RT, Journal of molecular medicine (Berlin, Germany), 2011 Mar; 89 (3):229-36

Honors/Awards

Damon Runyon Cancer Research Foundation Clinical Investigator Award

(2011)

President’s Research Council Distinguished Young Researcher Award

(2008)

Soc. for Inherited Metabolic Disorders Neil Buist Award

(2008)

Sowell Family Scholar in Medical Research

(2008)

William K. Bowes, Jr. Award in Medical Genetics

(2008)

CHOP Pediatric Scholars Program & Faculty Honor Roll

(2007)

Professional Associations/Affiliations

American Academy of Pediatrics

American Association for Cancer Research

American Society of Human Genetics

Society for Inherited Metabolic Disorders

Society for Pediatrics Research